Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) insider Johanna Friedl-Naderer sold 900 shares of the company’s stock in a transaction on Friday, September 4th. The shares were sold at an average price of $24.35, for a total transaction of $21,915.00. Following the completion of the transaction, the insider owned 153,082 shares of the company’s […]

Maze Therapeutics, Inc. (NASDAQ:MAZE – Get Free Report) insider Phillips Courtney sold 1,981 shares of the company’s stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $26.47, for a total value of $52,437.07. Following the completion of the sale, the insider directly owned 9,019 shares of the […]

Maze Therapeutics, Inc. (NASDAQ:MAZE – Get Free Report) CEO Jason Coloma sold 11,227 shares of the stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $26.47, for a total transaction of $297,178.69. Following the completion of the transaction, the chief executive officer owned 38,773 shares of the […]

Maze Therapeutics, Inc. (NASDAQ:MAZE – Get Free Report) insider Atul Dandekar sold 3,243 shares of the stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $26.01, for a total value of $84,350.43. Following the completion of the sale, the insider directly owned 32,316 shares in the company, […]

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) insider Roberto Wandenkolk Vieira sold 58,333 shares of Corcept Therapeutics stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $110.76, for a total transaction of $6,460,963.08. Following the completion of the transaction, the insider directly owned 4,242 […]